GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeraMED Ltd (FRA:1I4) » Definitions » Days Sales Outstanding

HeraMED (FRA:1I4) Days Sales Outstanding : 277.04 (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is HeraMED Days Sales Outstanding?

HeraMED's average Accounts Receivable for the six months ended in Dec. 2024 was €0.17 Mil. HeraMED's Revenue for the six months ended in Dec. 2024 was €0.11 Mil. Hence, HeraMED's Days Sales Outstanding for the six months ended in Dec. 2024 was 277.04.

The historical rank and industry rank for HeraMED's Days Sales Outstanding or its related term are showing as below:

FRA:1I4' s Days Sales Outstanding Range Over the Past 10 Years
Min: 15.87   Med: 390.44   Max: 1778.48
Current: 252.69

During the past 7 years, HeraMED's highest Days Sales Outstanding was 1778.48. The lowest was 15.87. And the median was 390.44.

FRA:1I4's Days Sales Outstanding is ranked worse than
94.37% of 817 companies
in the Medical Devices & Instruments industry
Industry Median: 65.94 vs FRA:1I4: 252.69

HeraMED's Days Sales Outstanding increased from Dec. 2023 (274.79) to Dec. 2024 (277.04).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


HeraMED Days Sales Outstanding Historical Data

The historical data trend for HeraMED's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeraMED Days Sales Outstanding Chart

HeraMED Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Sales Outstanding
Get a 7-Day Free Trial 1,756.56 902.89 16.02 68.88 123.60

HeraMED Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 242.12 199.49 274.79 361.74 277.04

Competitive Comparison of HeraMED's Days Sales Outstanding

For the Medical Devices subindustry, HeraMED's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeraMED's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeraMED's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where HeraMED's Days Sales Outstanding falls into.


;
;

HeraMED Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

HeraMED's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

Days Sales Outstanding (A: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (0.128 + 0.021) / 2 ) / 0.22*365
=0.0745 / 0.22*365
=123.60

HeraMED's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding (Q: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2024 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (0.316 + 0.021) / 2 ) / 0.111*365 / 2
=0.1685 / 0.111*365 / 2
=277.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HeraMED  (FRA:1I4) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


HeraMED Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of HeraMED's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


HeraMED Business Description

Traded in Other Exchanges
Address
201, 697 Burke Road, Suite 4, Camberwell, VIC, AUS, 3124
HeraMED Ltd is engaged in developing, connected pregnancy monitoring solutions for home and professional use. It has developed a foetal heartbeat monitor called HeraBEAT which is a medical-grade, clinically-validated, smart and connected Ultrasound Foetal Doppler device predominantly for use by an expectant mother to self-monitor her foetus' heart rate (FHR). It is also focused on the commercialization and deployment of its HeraCARE pregnancy monitoring solution. Geographically, the company generates a majority of its revenue from the United States of America followed by Australia and Israel.

HeraMED Headlines

No Headlines